background image

Lung Cancer Clinical Trials

Find clinical trials for lung cancer. Search for lung cancer clinical trials in different cities and states across the United States.

Filter
1
Active & ResponsiveNew

The Florida ASCENT Study

for
Cancer, Food Deprivation, Food Habits, Food Selection,
Location: 1 recruiting location
Sponsor: University of Florida

Sex: All

Age: 18 - 70+

Code: NCT07042243

Recruiting
Active & ResponsiveNew

Efficacy and Safety of a Single Dose of LS301-IT for Fluorescence Intraoperative Molecular Imaging (IMI) for Patients Undergoing Lung Cancer Resection for Non Small Cell Lung Cancer

for
Non Small Cell Lung Cancer (NSCLC)
Location: 1 recruiting location
Sponsor: Integro Theranostics

Sex: All

Age: 18+

Code: NCT07276789

Phase2, Recruiting
Active & ResponsiveNew

Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis

for
Idiopathic Pulmonary Fibrosis
Location: 1 recruiting location
Sponsor: Contineum Therapeutics

Sex: All

Age: 40+

Code: NCT07284459

Phase2, Recruiting
Active & ResponsiveNew

A Phase 1 Clinical Trial of Siltuximab for the Treatment of Antibody-Mediated Rejection After Lung Transplantation

for
Antibody Mediated Rejection of Lung Transplant
Location: 2 recruiting locations
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT06990711

Phase1, Recruiting
Active & ResponsiveNew

Triple EIT (Electrical Impedance Tomography)

for
Neonates and Preterm Infants, Cardiopulmonary
Location: 1 recruiting location
Sponsor: University of Colorado, Denver

Sex: All

Age: 0 - 25

Code: NCT07247474

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & ResponsiveNew

Immunogenicity of RSVPreF3 Vaccine in Immunocompromised Persons

for
Respiratory Syncytial Virus (RSV)
Location: 1 recruiting location
Sponsor: Johns Hopkins University

Sex: All

Age: 18+

Code: NCT07050732

Phase2, Recruiting
Active & ResponsiveNew

KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)

for
Malignant Neoplasm
Location: 1 recruiting location
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07252739

Phase2, Recruiting
Active & Responsive

Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer

for
Small-cell Lung Cancer
Location: 1 recruiting location
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT04342429

Recruiting
Active & Responsive

A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

for
Advanced or Metastatic Solid Tumors, Breast Cancer,
Location: 21 recruiting locations
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT05787587

Phase1, Recruiting
Active & Responsive

Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)

for
Metastatic Non Small Cell Lung Cancer
Location: 32 recruiting locations
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT05555732

Phase3, Recruiting